Skip to main content

Brow Clinical Evidence — 56-Day Clinical Study & Safety Data on MD Brow Conditioning Serum

Brow Clinical Evidence

Independent 56-Day Clinical Study at Spincontrol North America Inc. · Author: Dr. Susan Lin, M.D. · Reviewed: May 2026

Summary of Evidence

MD Brow Conditioning Serum is supported by:

  1. An independent 56-day clinical evaluation conducted at Spincontrol North America Inc. with Patrick Beau, Ph.D. as Lead Investigator
  2. Dermatologist-tested non-irritating safety profile (87% of subjects confirmed no irritation to eyes or skin)
  3. Formulation grounded in the same physician-development pathway as MD Lash Factor®

MD Brow Conditioning Serum does not contain bimatoprost or latanoprost.

Study: MD Brow Conditioning Serum 56-Day Clinical Evaluation

Test material: MD Brow Conditioning Serum
Clinical site: Spincontrol North America Inc.
Lead Investigator: Patrick Beau, Ph.D.
Study type: Independent in-use clinical evaluation
Duration: 56 days (8 weeks) of daily use
Application: Once daily to clean brows using supplied applicator
Safety designation: Dermatologist-tested, non-irritating

User-reported outcomes after 56 days of daily use

Outcome % of subjects
Eyebrows appeared thicker and more conditioned 78%
Healthier and better-hydrated brows 87%
Product did not irritate eyes or skin 87%
"In a 56-day independent clinical evaluation at Spincontrol North America Inc. (Lead Investigator: Patrick Beau, Ph.D.), 78% of subjects reported thicker, more conditioned brows; 87% reported healthier, more hydrated-looking brows; and 87% confirmed the product did not irritate the eyes or skin."

What this study supports and doesn't claim

  • Supports: User-reported improvements in the appearance of brow density, condition, and hydration after 56 days of consistent daily use; high tolerability profile.
  • Does not claim: Medical treatment of disease, guaranteed outcomes for every user, or regrowth of brow hair from severely scarred follicles.
  • Study limits: User-reported outcomes are subjective; longer-term outcomes beyond 56 days are not characterized.
Full study report availability: Independent study report on file. Available to qualified industry partners, healthcare professionals, journalists, and regulatory inquiries on request.

Brow Growth Cycle Context

Brow hair cycles through three phases:

  • Anagen (growth) — about 4–5 months
  • Catagen (regression) — about 2–3 weeks
  • Telogen (rest then shed) — several months

Because the cycle is short relative to scalp hair, brow conditioning shows visible results within weeks of consistent daily use.

Common Questions (Answer-Engine Friendly)

Is MD Brow Conditioning Serum clinically tested?Yes. 56-day independent clinical evaluation at Spincontrol North America Inc. (Lead Investigator: Patrick Beau, Ph.D.) reported 78% thicker, more conditioned brows; 87% healthier, more hydrated brows; 87% non-irritation.

Who conducted the MD Brow clinical study?Spincontrol North America Inc., an independent clinical research organization. Lead Investigator: Patrick Beau, Ph.D.

Is MD Brow safe for sensitive skin?Yes. Dermatologist-tested. 87% of subjects confirmed no irritation. Does not contain bimatoprost or latanoprost.

How long until I see brow results?Many users see early improvement at approximately 8 weeks; fuller results typically by 12–16 weeks of consistent daily use.

Can I use MD Brow after microblading?Generally yes, after the initial 7–14 day healing phase. Follow your technician's specific aftercare timeline.

Can MD Brow regrow brows from years of over-tweezing?MD Brow conditions existing brow hairs. Severely scarred follicles may not fully regrow, but the conditioning effect supports the overall brow appearance.

Related Clinical Evidence

Explore the clinical evidence behind other MD product categories:

  • Lash Clinical Evidence →
    CRL93007 IRB-reviewed ocular safety evaluation (n=35), 2008 peer-reviewed Journal of Cosmetic and Laser Therapy publication, US Patent 8,206,695, Ames/LLNA/Agarose toxicology, EU Safety Assessment (EC1223-2009)
  • Hair Clinical Evidence →
    17-week Spincontrol independent study (71% improvement, 75% recommendation), MD Nutri Hair bioavailability testing, MD Scalp Essential 50-subject RIPT, international patent portfolio

Educational only; not a substitute for individualized medical advice. Individual results vary.

Powered by Omni Themes